186 related articles for article (PubMed ID: 6706305)
21. Oral cholelitholysis--cheno versus urso: Japanese experience.
Nakayama F
Dig Dis Sci; 1980 Feb; 25(2):129-34. PubMed ID: 6986241
[TBL] [Abstract][Full Text] [Related]
22. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
Iwamura K
Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
[TBL] [Abstract][Full Text] [Related]
23. Faecal bile acid loss and bile acid pool size during short-term treatment with ursodeoxycholic and chenodeoxycholic acid in patients with radiolucent gallstones.
Salvioli G; Salati R
Gut; 1979 Aug; 20(8):698-704. PubMed ID: 488763
[TBL] [Abstract][Full Text] [Related]
24. Pharmaceutical dissolution of gallstones.
JAMA; 1983 Nov; 250(17):2373-4. PubMed ID: 6355529
[No Abstract] [Full Text] [Related]
25. Outcome of chenodeoxycholic acid (CDCA) treatment in 125 patients with radiolucent gallstones. Factors influencing efficacy, withdrawal, symptoms and side effects and post-dissolution recurrence.
Maton PN; Iser JH; Reuben A; Saxton HM; Murphy GM; Dowling RH
Medicine (Baltimore); 1982 Mar; 61(2):86-97. PubMed ID: 7062856
[TBL] [Abstract][Full Text] [Related]
26. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
Tint GS; Salen G; Shefer S
Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
[TBL] [Abstract][Full Text] [Related]
27. Analysis of response to ursodeoxycholic acid for gallstone dissolution.
Bateson MC; Hill A; Bouchier IA
Digestion; 1980; 20(5):358-64. PubMed ID: 7390061
[TBL] [Abstract][Full Text] [Related]
28. [Dissolution of gallstones based on 6 months treatment with a single daily dose of ursodeoxycholic acid].
Realini S; Gonvers JJ; Arnold J; Borel GA; Bretholz A; Capitaine Y; Hofstetter JR; Bettini L; di Simone A
Schweiz Med Wochenschr; 1983 Apr; 113(17):641-2. PubMed ID: 6867654
[TBL] [Abstract][Full Text] [Related]
29. Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids. Studies of safety, efficacy and effects on bile lithogenicity, bile acid pool, and serum lipids.
Roehrkasse R; Fromm H; Malavolti M; Tunuguntla AK; Ceryak S
Dig Dis Sci; 1986 Oct; 31(10):1032-40. PubMed ID: 3757719
[TBL] [Abstract][Full Text] [Related]
30. [Dissolution of gallstones by chenodeoxycholic acid].
Brändli HH; Hefti ML; Blum AL
Schweiz Med Wochenschr; 1977 Dec; 107(48):1770-3. PubMed ID: 337470
[TBL] [Abstract][Full Text] [Related]
31. Comparison on Response and Dissolution Rates Between Ursodeoxycholic Acid Alone or in Combination With Chenodeoxycholic Acid for Gallstone Dissolution According to Stone Density on CT Scan: Strobe Compliant Observation Study.
Lee JM; Hyun JJ; Choi IY; Yeom SK; Kim SY; Jung SW; Jung YK; Koo JS; Yim HJ; Lee HS; Lee SW; Kim CD
Medicine (Baltimore); 2015 Dec; 94(50):e2037. PubMed ID: 26683912
[TBL] [Abstract][Full Text] [Related]
32. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
[TBL] [Abstract][Full Text] [Related]
33. Combination therapy with oral ursodeoxycholic and chenodeoxycholic acids: pretreatment computed tomography of the gall bladder improves gall stone dissolution efficacy.
Walters JR; Hood KA; Gleeson D; Ellul JP; Keightley A; Murphy GM; Dowling RH
Gut; 1992 Mar; 33(3):375-80. PubMed ID: 1568659
[TBL] [Abstract][Full Text] [Related]
34. Medical treatment of gallstones.
Iser J
Aust Fam Physician; 1981 Jun; 10(6):492-4. PubMed ID: 7283856
[No Abstract] [Full Text] [Related]
35. Acquired gallstone opacification during cholelitholytic treatment with chenodeoxyholic, ursodeoxycholic, and tauroursodeoxycholic acids.
Bazzoli F; Festi D; Mazzella G; Frabboni R; Zagari RM; Fossi S; Pozzato P; Sottili S; Simoni P; Roda A
Am J Gastroenterol; 1995 Jun; 90(6):978-81. PubMed ID: 7771434
[TBL] [Abstract][Full Text] [Related]
36. Clinical studies on dissolution of gallstones using ursodeoxycholic acid.
Okumura M; Tanikawa K; Chúman Y; Kóji T; Nakagawa S; Nakamura Y; Iino H; Yamasaki S; Hisatsugu T
Gastroenterol Jpn; 1977; 12(6):469-75. PubMed ID: 608570
[TBL] [Abstract][Full Text] [Related]
37. Current problem of chemical gallstone dissolution.
Leuschner U
Tokai J Exp Clin Med; 1983 May; 8(2):117-27. PubMed ID: 6419403
[No Abstract] [Full Text] [Related]
38. The UDCA dosage deficit: a fate shared with CDCA.
Roda E; Liva S; Ferrara F; Azzaroli F; Giovanelli S; Nigro G; Festi D; Mazzella G
Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):213-6. PubMed ID: 11953683
[TBL] [Abstract][Full Text] [Related]
39. Medical treatment of cholesterol gallstones by bile desaturating agents.
Hofmann AF
Hepatology; 1984; 4(5 Suppl):199S-208S. PubMed ID: 6384003
[No Abstract] [Full Text] [Related]
40. Oral dissolution therapy for cholelithiasis: mix and match.
Phillips RS; Barkin JS
Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
